There’s no pleasing some people. Abbott (NYSE:ABT) shares were down on Wall Street today, despite the health care products giant reporting strong second-quarter sales and earnings figures ’ including a nearly 100 percent top-line surge for its coronary stents business.The Abbott Park, Ill.-based conglomerate reported profits of $1.94 billion, or $1.23 per diluted share, on [...]

Medical equipment supplier Medline Industries has been approved for an Ohio tax credit for an expansion of its Cincinnati manufacturing facility.The Cincinnati project will involve a $2 million investment in machinery and equipment and building improvements by Medline to expand its “medical liquids” manufacturing capabilities, according to the Ohio Department of Development (ODOD).The 45 percent, [...]

An unknown bandit made off with a trailer shipment of Abbot Laboratories’ (NYSE:ABT) blood glucose monitoring products, and the company is working with law enforcement officials to get it back.In the mean time, the company warned pharmacies and consumers against products with unusually low prices as an indication that they might be [...]

Updated 4:06 p.m.North Carolina life sciences company Entegrion has licensed its blood-clotting bandage to newly formed Chicago company Beeken BioMedical.Research Triangle Park-based Entegrion developed the bandage, called Stasilon, which is made of a proprietary weave of glass and bamboo fibers, two materials that promote clotting. Entegrion has received U.S. Food and Drug Administration clearance for [...]

The Food & Drug Administration slapped Medela Inc. with a warning letter related to reports that the company’s breast pumps were smoking or catching fire.The company had received 14 complaints about its Pump in Style Advanced electric breast pump that tell of the device’s motors and transformers failing during use, [...]

Australian company Cavitus is eyeing North Carolina’s Research Triangle Park region as a possible site to relocate its headquarters. The company is planning the move to be closer to existing customers and to find new ones in the pharmaceutical industry. Other cities in the running include Boston and Chicago.

Abbott had solid earnings to report, but problems in the pharmaceuticals portion of its business are triggering job cuts. About 2 percent of the company’s global workforce will be let go. Its earnings–per-share expectations are also considered low.

Abbott Laboratories Inc. (NYSE:ABT) goes before a Food & Drug Administration panel today, seeking to expand the indication for its RX Acculink carotid artery stent.

Health insurance companies have increasingly relied on data-driven decision-making based on claims data. Blue Health Intelligence, a data analysis business for Blue Cross and Blue Shield Plans, was created to help members as healthcare shifted to an evidence-based, decision-making model. BCBS will spin off the service into its own company and has sent aside $28 million for the shift.

Eugene Goldwasser discovery’s of erythropoietin (EPO) helped launch the biotech industry. EPO itself has been controversial at times – subsidized by the government and abused by athletes. But Goldwasser’s lengthy and publicly funded search for the protein was nothing but amazing. He passed away on Friday.